BackStraumann Holding AG Overview

Straumann Holding AG EBIT

Track Straumann Holding AG's EBIT ($1.6B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$267.36M
24.72% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$1.60B
70.4% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Straumann Holding AG (SAUHF) FAQ

The latest EBIT for SAUHF is $1.6B as of June 2026. That compares with $940M in the prior-year period — up 70.4% year over year. That is below the Healthcare sector average of $23B. Investors often review this figure alongside Straumann Holding AG's historical trend and sector peers before judging valuation or financial health.

Over the past year, SAUHF's EBIT moved from $940M to $1.6B — a 70.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Straumann Holding AG's operating scale or balance-sheet position.

Against Healthcare companies, SAUHF currently prints $1.6B for EBIT, while the sector average sits near $23B. That is roughly 93.0% below the sector mean. Large gaps often invite a closer look at Straumann Holding AG's growth, margins, and balance sheet.

A EBIT figure of $1.6B for SAUHF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $23B. Explore the charts below for those layers of context.

After noting SAUHF's EBIT ($1.6B), review year-over-year change from $940M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.